O’Shaughnessy, Joyce http://orcid.org/0000-0001-6764-2807
Funding for this research was provided by:
Novartis
Article History
Received: 28 April 2020
Accepted: 9 May 2020
First Online: 20 May 2020
Compliance with ethical standards
:
: Dr. O’Shaughnessy reports AbbVie Inc., Agendia, Amgen Biotechnology, AstraZeneca, Bristol-Myers Squibb, Celgene Corporation, Eisai, Genentech, Genomic Health, GRAIL, Immunomedics, Heron Therapeautics, Ipsen Biopharmaceuticals, Jounce Therapeutics, Lilly, Merck, Myriad, Novartis, Ondonate Therapeutics, Pfizer, Puma Biotechnology, Prime Oncology, Roche, Seattle Genetics, Syndax Pharmaceuticals.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Not applicable.